CVS Health (CVS) Tops Q3 EPS by 23c, Beats on Revenue; Offers FY25 EPS Guidance
Tweet
Share
E-mail
Get Alerts CVS Hot Sheet
Price: $87.72 -1.26%
Revenue Growth %: +1.3%
Financial Fact:
Net loss attributable to noncontrolling interest: -1M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: +1.3%
Financial Fact:
Net loss attributable to noncontrolling interest: -1M
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
CVS Health (NYSE: CVS) reported Q3 EPS of $1.60, $0.23 better than the analyst estimate of $1.37. Revenue for the quarter came in at $102.9 billion versus the consensus estimate of $98.88 billion.
GUIDANCE:
CVS Health sees FY2025 EPS of $6.55-$6.65, versus the consensus of $6.38.
For earnings history and earnings-related data on CVS Health (CVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Mosaic (MOS), Others Lower Following Trump Post on Potash from Belarus
- Bank of Canada warns new US tariffs may cut Q4 growth below 1%
- Scandium Canada names Noel Dubé to its board of directors
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
